345 related articles for article (PubMed ID: 30294913)
21. The Human RNA Surveillance Factor UPF1 Modulates Gastric Cancer Progression by Targeting Long Non-Coding RNA MALAT1.
Li L; Geng Y; Feng R; Zhu Q; Miao B; Cao J; Fei S
Cell Physiol Biochem; 2017; 42(6):2194-2206. PubMed ID: 28942451
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 inhibits the proliferation and migration of bladder cancer cells by modulating the microRNA-34a/cyclin D1 axis.
Liu Y; Gao S; Du Q; Zhao Q
Int J Mol Med; 2019 Jan; 43(1):547-556. PubMed ID: 30387807
[TBL] [Abstract][Full Text] [Related]
24. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression.
Jen J; Tang YA; Lu YH; Lin CC; Lai WW; Wang YC
Mol Cancer; 2017 Jun; 16(1):104. PubMed ID: 28615056
[TBL] [Abstract][Full Text] [Related]
25. Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide.
Li H; Yuan X; Yan D; Li D; Guan F; Dong Y; Wang H; Liu X; Yang B
Cell Physiol Biochem; 2017; 42(3):1192-1201. PubMed ID: 28668966
[TBL] [Abstract][Full Text] [Related]
26. The Long Non-Coding RNA MALAT1 Enhances Ovarian Cancer Cell Stemness by Inhibiting YAP Translocation from Nucleus to Cytoplasm.
Wu X; Wang Y; Zhong W; Cheng H; Tian Z
Med Sci Monit; 2020 May; 26():e922012. PubMed ID: 32433460
[TBL] [Abstract][Full Text] [Related]
27. METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/
Li C; Liu J; Lyu Y; Ling S; Luo Y
Anal Cell Pathol (Amst); 2023; 2023():9952234. PubMed ID: 37927399
[TBL] [Abstract][Full Text] [Related]
28. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells.
Liu S; Song L; Zeng S; Zhang L
Tumour Biol; 2016 Jan; 37(1):633-40. PubMed ID: 26242259
[TBL] [Abstract][Full Text] [Related]
29. The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion.
Braeutigam C; Rago L; Rolke A; Waldmeier L; Christofori G; Winter J
Oncogene; 2014 Feb; 33(9):1082-92. PubMed ID: 23435423
[TBL] [Abstract][Full Text] [Related]
30. Long Non-coding RNA
Yim GW; Kim HJ; Kim LK; Kim SW; Kim S; Nam EJ; Kim YT
Cancer Res Treat; 2017 Jul; 49(3):656-668. PubMed ID: 27737536
[TBL] [Abstract][Full Text] [Related]
31. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma.
Xiao H; Tang K; Liu P; Chen K; Hu J; Zeng J; Xiao W; Yu G; Yao W; Zhou H; Li H; Pan Y; Li A; Ye Z; Wang J; Xu H; Huang Q
Oncotarget; 2015 Nov; 6(35):38005-15. PubMed ID: 26461224
[TBL] [Abstract][Full Text] [Related]
32. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
Yu J; Han Q; Cui Y
Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
Zuo Y; Li Y; Zhou Z; Ma M; Fu K
Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
[TBL] [Abstract][Full Text] [Related]
34. Alternative microexon splicing by RBFOX2 and PTBP1 is associated with metastasis in colorectal cancer.
Mochizuki Y; Funayama R; Shirota M; Kikukawa Y; Ohira M; Karasawa H; Kobayashi M; Ohnuma S; Unno M; Nakayama K
Int J Cancer; 2021 Nov; 149(10):1787-1800. PubMed ID: 34346508
[TBL] [Abstract][Full Text] [Related]
35. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells.
Gutschner T; Hämmerle M; Eissmann M; Hsu J; Kim Y; Hung G; Revenko A; Arun G; Stentrup M; Gross M; Zörnig M; MacLeod AR; Spector DL; Diederichs S
Cancer Res; 2013 Feb; 73(3):1180-9. PubMed ID: 23243023
[TBL] [Abstract][Full Text] [Related]
36. MALAT1 long non-coding RNA in cancer.
Yoshimoto R; Mayeda A; Yoshida M; Nakagawa S
Biochim Biophys Acta; 2016 Jan; 1859(1):192-9. PubMed ID: 26434412
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer.
Xu S; Sui S; Zhang J; Bai N; Shi Q; Zhang G; Gao S; You Z; Zhan C; Liu F; Pang D
Int J Clin Exp Pathol; 2015; 8(5):4881-91. PubMed ID: 26191181
[TBL] [Abstract][Full Text] [Related]
39. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
40. Long Noncoding RNA MALAT1 Regulates Hepatocellular Carcinoma Growth Under Hypoxia via Sponging MicroRNA-200a.
Zhao ZB; Chen F; Bai XF
Yonsei Med J; 2019 Aug; 60(8):727-734. PubMed ID: 31347327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]